MRMario Ruiz

Mario Ruiz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mario Ruiz has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antimicrobial Compounds From Aspergillus chevalieri Associated With the Gut Microbiota of Hermetia illucens Larvae Targeting Salmonella enterica Serovar Pullorum

    by Mario Ruiz, Billy Cabanillas, Mohamed Haddad, Alvaro Díaz, Michel Sauvain, Denis Castillo

    Background: The gut microbiota of insects represents an underexplored reservoir of bioactive compounds with potential antimicrobial applications. This study is aimed at identifying antimicrobial compounds from fungi associated with the gut microbiota of Hermetia illucens (black soldier fly) larvae active against Salmonella enterica serovar Pullorum, an important poultry pathogen. Methods: Fungi isolated from H. illucens larval gut were screened for antimicrobial activity against S. enterica serovar Pullorum. The active fungus was identified through molecular analysis of ITS, benA, and CaM regions. Ethyl acetate extract from the fungal culture was assessed for antimicrobial activity, followed by bioguided fractionation using preparative and semipreparative chromatography. Active fractions were analyzed using UHPLC/HRMS, and putative compound identification was performed through mass spectrometry and molecular networking. Result: Aspergillus chevalieri was identified as active against S. enterica serovar Pullorum, with the ethyl acetate extract exhibiting moderate antimicrobial activity (MIC = 4.00 mg/mL; IC 50 = 3.00 ± 0.58 mg/mL). Bioguided fractionation resulted in several active fractions. UHPLC/HRMS analysis putatively annotated 10 compounds, previously shown to be bioactive, including diketopiperazines (Neoechinulin A and echinulin), peptide derivatives (cyclo(L‐Tyr‐L‐Pro) and N ‐acetyltyramine), a benzofuran derivative, an isocoumarin (diaporthin), a flavin (lumichrome), an aminopurine (isopentenyladenine), and two diterpenoids (4‐deoxyphorbol‐13‐acetate and austinoneol). Conclusion: This study represents the first report of A. chevalieri associated with H. illucens larvae and demonstrates its potential as a source of antimicrobial compounds against S. enterica serovar Pullorum. The identified bioactive compounds provide promising leads for the development of new antimicrobial agents for poultry health.


  • Open Access

    In vitroantifungal evaluation of chitosan with essential oils fromCitrus x aurantifolia(Christm.) Swingle “sutil lemon” and Origanum vulgareL. “oregano” against Botrytis cinereaPers. “gray mold”

    by Mario Ruiz, Juan Ramos

    El objetivo de este estudio fue determinar la eficacia de la aplicación de quitosano (QUI) y aceites esenciales de Citrus x aurantifolia (AECA) y Origanum vulgare (AEOV) para prevenir infecciones por Botrytis cinerea, causante del moho gris en tomates. Todas las concentraciones probadas in vitro de AEOV (10 µL/mL, 5 µL/ml, 2,5 µL/mL y 1,25 µL/mL) y QUI (4 mg/mL y 8 mg/mL) resultaron en un 100% ICM para B. cinerea. Por otro lado, AECA 20 µL/mL originó valores entre 40-47% ICM. Estos resultados sugieren que los tratamientos compuestos por QUI, AECA y AEOV pueden llegar a ser un tratamiento alternativo prometedor contra B. cinerea debido a su carácter natural, la actividad antimicrobiana mejorada y al no desarrollar resistencia en los patógenos.